Home
>
National Drug Code (NDC)
>
Carvedilol
Carvedilol - 13107-145-05 - (Carvedilol)
Drug Information of Carvedilol
| Product NDC: | 13107-145 |
| Proprietary Name: | Carvedilol |
| Non Proprietary Name: | Carvedilol |
| Active Ingredient(s): | 25 mg/1 & nbsp; Carvedilol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carvedilol
| Product NDC: | 13107-145 |
| Labeler Name: | Aurolife Pharma LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078332 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090323 |
Package Information of Carvedilol
| Package NDC: | 13107-145-05 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (13107-145-05) |
NDC Information of Carvedilol
| NDC Code | 13107-145-05 |
| Proprietary Name | Carvedilol |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (13107-145-05) |
| Product NDC | 13107-145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carvedilol |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090323 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurolife Pharma LLC |
| Substance Name | CARVEDILOL |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC] |
